Edmond Fleischer Selected Research

deoxyartemisinin

1/2021

Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edmond Fleischer Research Topics

Disease

14	Neoplasms (Cancer) 06/2022 - 01/2019
3	Multiple Myeloma 04/2022 - 07/2020
3	Leukemia 12/2021 - 07/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 06/2021 - 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Colitis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Carcinogenesis 01/2021
1	Cardiotoxicity 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Necrosis 07/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2017

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 12/2021 - 09/2019
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 01/2020
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 06/2022 - 11/2021
2	Biological ProductsIBA 04/2022 - 01/2021
2	Aurora Kinase AIBA 04/2022 - 01/2021
2	chlorothricinIBA 04/2022 - 01/2021
2	resazurinIBA 01/2021 - 07/2020
2	Vitamin K 3 (Menadione)FDA Link 10/2020 - 01/2020
1	nobiletinIBA 06/2022
1	NaphthoquinonesIBA 01/2022
1	Dextran SulfateIBA 01/2022
1	moniliforminIBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2021
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 11/2021
1	isopetasinIBA 06/2021
1	XenobioticsIBA 06/2021
1	N- (4- ((3- (2- amino- 4- pyrimidinyl)- 2- pyridinyl)oxy)phenyl)- 4- (4- methyl- 2- thienyl)- 1- phthalazinamineIBA 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	LigandsIBA 01/2021
1	artemisinin GIBA 01/2021
1	artemisinin BIBA 01/2021
1	deoxyartemisininIBA 01/2021
1	ZincIBA 01/2021
1	artenimol (dihydroartemisinin)IBA 01/2021
1	artemisinin (artemisinine)IBA 01/2021
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2021
1	salvinIBA 10/2020
1	TubulinIBA 10/2020
1	AntioxidantsIBA 10/2020
1	secalonic acidIBA 07/2020
1	Syntex adjuvant formulationIBA 07/2020
1	Vitamin K FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 09/2019
1	multidrug resistance-associated protein 1IBA 01/2019
1	lawsoneIBA 12/2017
1	CateninsIBA 12/2017

Therapy/Procedure

5	Therapeutics 06/2022 - 01/2019
4	Drug Therapy (Chemotherapy) 06/2021 - 01/2019